Home - Products - Others - Other Targets - Theralizumab

Theralizumab

CAS No. 906068-56-2

Theralizumab( —— )

Catalog No. M36814 CAS No. 906068-56-2

Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	1881	In Stock
10MG	3164	In Stock
25MG	4722	In Stock
50MG	6212	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Theralizumab
Note

Research use only, not for human use.
Brief Description

Theralizumab (TGN1412) is an anti-CD28-targeting monoclonal antibody that directly stimulates T cells.
Description

Theralizumab (TGN1412) is a superagonist anti-CD28 monoclonal antibody that directly stimulates T cells. Theralizumab can be used for the research of rheumatoid arthritis.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

906068-56-2
Formula Weight
Molecular Formula

——
Purity

>98% (HPLC)
Solubility

——
SMILES

——
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Thomas Hünig. The rise and fall of the CD28 superagonist TGN1412 and its return as TAB08: a personal account. FEBS J. 2016 Sep;283(18):3325-34.?

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Praeruptorin B

Praeruptorin B can inhibit tumor promoter induced phemonenon in vitro.
LW6

LW6 is a novel HIF-1 inhibitor.
Brilliant Black BN

Brilliant black BN (E151) is an azo dye and a food colorant. It is a promising antiviral agent against EV71 infection via inhibiting the interaction between EV71 and its cellular uncoating factor cyclophilin A.

Sign In Join Free